Remuneration figures for 2025-2026 presented

The Health Insurance Fund has released official remuneration figures for the years 2025-2026 as a prelude to upcoming negotiations. Pierre-Olivier Variot, president of the Union of Retail Pharmacists' Unions (USPO), described the figures as "consistent with the data from Iqvia and the Gers," referring to two major sources of health data in France.

Delay and impact of price reductions noted

Variot pointed out a 50 million euro delay compared to the expected trend, adding that the impact of price reductions for medicines in early 2026 is estimated at around 80 million euros. This could affect the overall remuneration for pharmacies.

FSPF calls for review clause

The Federation of French Pharmaceutical Unions (FSPF) claims the accounts do not balance and has officially requested the triggering of the review clause. Julien Chauvin, president of the Studies and Economic Strategy Committee within the FSPF, said the National Health Insurance Fund - Cnam is not opposed but wants some figures to be revised, with the unions set to provide them.

Proposals to revise remuneration

The meeting addressed the project to revise the official remuneration, which will be included in the 4th addendum to the national pharmaceutical convention. The FSPF and the USPO have proposed ideas to reduce the sensitivity of remuneration to the number of boxes sold, by increasing the remuneration per prescription.

Need for investment and sustainable reform

Chauvin noted that the Cnam is not closed to this approach but emphasizes the need for investment from the Health Insurance Fund to ensure no pharmacies are negatively affected by the reform. The USPO shares this view, stressing the importance of a sustainable reform that considers inflation, the increase in the point (a unit of remuneration), and other factors that could impact their remuneration.

Planned working group in November

Another working group is planned for November between the unions and the Health Insurance Fund, indicating ongoing discussions and potential adjustments to the remuneration model.